MedGen Inc (MDIN)

[Jammin1]

As someone else already replied, the $5 million revenue mark was for distribution deals, and is considered deferred revenue. They don't actually "get" the revenue until product is sold to the end user, and little if any of that has been actually sold, or even reached shelves yet.

The last 2 reported quarters' revenues were: $153k and $82k (if my memory is correct). Before those 2 quarters, they had almost no revenues for the previous 4 years.

Their fiscal year ends Sept 30th, so we're about to get a report for Q1, and we're currently in Q2.

I expect them to be a little over $100k for the quarter they're about to report (Q1), and closer to $200k for the quarter ending March (Q2). After that it just depends on the success of new products and how well they grow distribution of existing ones, which is anybody's guess. It could explode upward for Q3, or only grow slightly.

A lot depends on how quickly they can get the lactose intolerance and MMJ products to market.